Methods | A crossover trial with 21 day treatment periods. Double blind. Randomization method not stated. Method of allocation concealment not stated. |
|
Participants | Institutionalized adult patients with uncontrolled epilepsy. 91% of participants had partial epilepsy. Number randomized = PHB group = 45 people, PHT group = 45 people. 62% of participants were male. Age range 18-51 years. |
|
Interventions | Monotherapy with PHB or PHT. Median daily dose achieved not stated. |
|
Outcomes | Seizure frequency. Time to treatment withdrawal. |
|
Notes | ||
Risk of bias | ||
Item | Authors’ judgement | Description |
Allocation concealment? | Unclear | B - Unclear |